Literature DB >> 11942535

Pathology of lethal fetal growth retardation syndrome with aminoaciduria, iron overload, and lactic acidosis (GRACILE).

Juhani Rapola1, Päivi Heikkilä, Vineta Fellman.   

Abstract

Autopsy study of 17 newborn infants with lethal autosomal recessive disease presenting as growth retardation with lactic acidosis, Fanconi aminoaciduria, and hepatic hemosiderosis is reported. The patients succumbed between day 1 and 4 months of life; 9 patients died within the first month. All patients showed severe pathologic changes of liver with cholestasis in all livers. Extensive accumulation of stainable iron of the hepatocytes was present in 9/17 autopsy tissues and in two biopsy specimens. Moderate to abundant iron storage in the Kupffer cells was seen in all liver specimens. The amount of hepatocytic iron was high in livers up to 1 month of age and decreased thereafter. The general features and liver findings of this disorder suggest the name Growth Retardation Aminoaciduria Cholestasis Iron Overload, Lactacidosis and Early Death (GRACILE, OMIM 603358). Calcified concrements were seen in the medulla of 13/16 kidney specimens. Pancreas of 13/14 patients showed interstitial fibrosis and exocrine atrophy. Various pathologic findings such as renal tubular dysgenesis, paucity of hepatic bile ducts and iron storage in the macrophages of spleen and pulmonary alveoli were observed in some cases. Previous extensive clinical genetic and laboratory investigations have revealed that the patients had a previously unrecognized genetic disease. It is inherited as an autosomal recessive trait. The gene locus is 2q33-37. The basic defect of the disease remains unknown.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11942535     DOI: 10.1080/15227950252852087

Source DB:  PubMed          Journal:  Pediatr Pathol Mol Med        ISSN: 1522-7952


  6 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 2.  Neonatal hemochromatosis.

Authors:  Amy G Feldman; Peter F Whitington
Journal:  J Clin Exp Hepatol       Date:  2013-11-27

Review 3.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

4.  GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L.

Authors:  Ilona Visapää; Vineta Fellman; Jouni Vesa; Ayan Dasvarma; Jenna L Hutton; Vijay Kumar; Gregory S Payne; Marja Makarow; Rudy Van Coster; Robert W Taylor; Douglass M Turnbull; Anu Suomalainen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-09-05       Impact factor: 11.025

5.  Respiratory chain complex III deficiency due to mutated BCS1L: a novel phenotype with encephalomyopathy, partially phenocopied in a Bcs1l mutant mouse model.

Authors:  Saara Tegelberg; Nikica Tomašić; Jukka Kallijärvi; Janne Purhonen; Eskil Elmér; Eva Lindberg; David Gisselsson Nord; Maria Soller; Nicole Lesko; Anna Wedell; Helene Bruhn; Christoph Freyer; Henrik Stranneheim; Rolf Wibom; Inger Nennesmo; Anna Wredenberg; Erik A Eklund; Vineta Fellman
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

6.  Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.

Authors:  Monika Oláhová; Camilla Ceccatelli Berti; Jack J Collier; Charlotte L Alston; Elisabeth Jameson; Simon A Jones; Noel Edwards; Langping He; Patrick F Chinnery; Rita Horvath; Paola Goffrini; Robert W Taylor; John A Sayer
Journal:  Hum Mol Genet       Date:  2019-11-15       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.